Amphastar Pharmaceuticals Aktie
16,92
EUR
-0,28
EUR
-1,63
%
19,66
USD
-0,47
USD
-2,31
%
Amphastar Pharmaceuticals jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Amphastar Pharmaceuticals Aktie Analyse
| 13.03.19 | Amphastar Pharmaceuticals Hold | Needham & Company, LLC | |
| 10.08.18 | Amphastar Pharmaceuticals Buy | Needham & Company, LLC | |
| 13.03.18 | Amphastar Pharmaceuticals Buy | Needham & Company, LLC | |
| 01.12.17 | Amphastar Pharmaceuticals Buy | Needham & Company, LLC | |
| 27.09.17 | Amphastar Pharmaceuticals Buy | Needham & Company, LLC | |
| 10.05.16 | Amphastar Pharmaceuticals Buy | Needham & Company, LLC | |
| 19.06.15 | Amphastar Pharmaceuticals Buy | Needham & Company, LLC |
Werbung
Werbung